Effects of hyperacute blood pressure and heart rate on stroke outcomes after intravenous tissue plasminogen activator

被引:27
|
作者
Tomii, Yasuhiro [1 ]
Toyoda, Kazunori [1 ]
Nakashima, Takahiro [1 ]
Nezu, Tomohisa [1 ]
Koga, Masatoshi [2 ]
Yokota, Chiaki [1 ]
Nagatsuka, Kazuyuki [3 ]
Minematsu, Kazuo [1 ]
机构
[1] Natl Cerebral & Cardiovasc Ctr, Dept Cerebrovasc Med, Suita, Osaka 5658565, Japan
[2] Natl Cerebral & Cardiovasc Ctr, Div Stroke Care Unit, Suita, Osaka 5658565, Japan
[3] Natl Cerebral & Cardiovasc Ctr, Dept Neurol, Suita, Osaka 5658565, Japan
基金
日本学术振兴会;
关键词
blood pressure; heart rate; hypertension; outcome; stroke; thrombolysis; tissue plasminogen activator; ACUTE ISCHEMIC-STROKE; SAFE IMPLEMENTATION; PROGNOSTIC-SIGNIFICANCE; DIFFERENT SUBTYPES; CLINICAL-TRIAL; THROMBOLYSIS; ALTEPLASE; ASSOCIATION; VARIABILITY; PREDICTORS;
D O I
10.1097/HJH.0b013e32834a764e
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Background and purpose The present study clarifies associations between stroke outcomes after intravenous tissue plasminogen activator (tPA) and blood pressure (BP) as well as heart rate (HR) profiles. Methods We assessed 125 patients with stroke who received tPA within 3 h of onset. We obtained baseline, mean, maximum, minimum, and coefficient of variation values for BP and HR during the initial 24 h. The primary outcome was independence at 3 months corresponding to a modified Rankin Scale score of 2 or less. The secondary outcomes were early neurological improvement at 24 h and intracerebral hemorrhage (ICH) within 36 h. Results Among the patients, 64 (51%) achieved independence, 66 (53%) early improvement, and 26 (21%) developed ICH. The 24-h time courses of SBP (P = 0.033), pulse pressure (PP, P = 0.007), and HR (P < 0.001) were lower among patients who reached independence than among those who did not. After multivariate adjustment, 24-h mean levels of SBP (odds ratio 0.69, 95% confidence interval 0.48-0.97, per 10-mmHg increase), PP (0.63, 0.41-0.94), and HR (0.59, 0.42-0.80, per 10-bpm increase) were inversely associated with independence, as were their maximum and minimum values. In particular, mean SBP values were inversely associated with independence at 8-16 and 16-24 h (0.73, 0.54-0.97 and 0.66, 0.47-0.91, respectively), but not at 0-8 h (0.79, 0.57-1.07). Baseline and maximum SBP were inversely associated with early improvement. Maximum and coefficient of variation of SBP were associated with ICH. Conclusion Lower SBP, PP, and HR values during the initial 24 h after tPA, especially at 8 h thereafter, were associated with independence at 3 months. J Hypertens 29:1980-1987 (C) 2011 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.
引用
收藏
页码:1980 / 1987
页数:8
相关论文
共 50 条
  • [41] Time to Treatment With Intravenous Tissue Plasminogen Activator and Outcome From Acute Ischemic Stroke
    Saver, Jeffrey L.
    Fonarow, Gregg C.
    Smith, Eric E.
    Reeves, Mathew J.
    Grau-Sepulveda, Maria V.
    Pan, Wenqin
    Olson, DaiWai M.
    Hernandez, Adrian F.
    Peterson, Eric D.
    Schwamm, Lee H.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (23): : 2480 - 2488
  • [42] Real-World Outcomes of Acute Ischemic Stroke Treatment with Intravenous Recombinant Tissue Plasminogen Activator
    Betts, Keith A.
    Hurley, Dana
    Song, Jinlin
    Sajeev, Gautam
    Guo, Jenny
    Du, Ella Xiaoyan
    Paschoalin, Marco
    Wu, Eric Q.
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2017, 26 (09) : 1996 - 2003
  • [43] Does Mild Deficit for Patients with Stroke Justify the Use of Intravenous Tissue Plasminogen Activator?
    Hassan, Ameer E.
    Zacharatos, Haralabos
    Hassanzadeh, Bahareh
    El-Gengaihy, Ahmed
    AlKawi, Ammar
    Shhadeh, Akram
    Kirmani, Jawad F.
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2010, 19 (02) : 116 - 120
  • [44] Racial and Ethnic Disparities in the Use of Intravenous Recombinant Tissue Plasminogen Activator and Outcomes for Acute Ischemic Stroke
    Nasr, Deena M.
    Brinjikji, Waleed
    Cloft, Harry J.
    Rabinstein, Alejandro A.
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2013, 22 (02) : 154 - 160
  • [45] Emergency Superficial Temporal Artery to Middle Cerebral Artery Bypass After Intravenous Administration of Tissue Plasminogen Activator for Stroke
    Takeuchi, Satoru
    Wada, Kojiro
    Arimoto, Hirohiko
    Kumagai, Kosuke
    Osada, Hideo
    Otani, Naoki
    Mori, Kentaro
    TURKISH NEUROSURGERY, 2015, 25 (04) : 633 - 637
  • [46] Very Mild Stroke Patients Benefit from Intravenous Tissue Plasminogen Activator Without Increase of Intracranial Hemorrhage
    Hassan, Ameer E.
    Hassanzadeh, Bahareh
    Tohidi, Vahid
    Kirmani, Jawad F.
    SOUTHERN MEDICAL JOURNAL, 2010, 103 (05) : 398 - 402
  • [47] Predictors of Long-term Outcome after Intravenous or Intra-arterial Recombinant Tissue Plasminogen Activator Treatment in the Eastern Hungarian Thrombolysis Database
    Fekete, Klara
    Marton, Sandor
    Toth, Judit
    Csiba, Laszlo
    Fekete, Istvan
    Bereczki, Daniel
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2015, 24 (01) : 117 - 124
  • [48] Intravenous thrombolysis in German stroke units before and after regulatory approval of recombinant tissue plasminogen activator
    Weimar, C.
    Kraywinkel, K.
    Maschke, M.
    Diener, H. -C.
    CEREBROVASCULAR DISEASES, 2006, 22 (5-6) : 429 - 431
  • [49] Hemothorax after the Intravenous Administration of Tissue Plasminogen Activator in a Patient with Acute Ischemic Stroke and Rib Fractures
    Shirokane, Kazutaka
    Umeoka, Katsuya
    Mishina, Masahiro
    Mizunari, Takayuki
    Kobayashi, Shiro
    Teramoto, Akira
    JOURNAL OF NIPPON MEDICAL SCHOOL, 2014, 81 (01) : 43 - 47
  • [50] Clinical deterioration after intravenous recombinant tissue plasminogen activator treatment - A multicenter transcranial Doppler study
    Saqqur, Maher
    Molina, Carlos A.
    Salam, Abdul
    Siddiqui, Muzaffar
    Ribo, Marc
    Uchino, Ken
    Calleja, Sergio
    Garami, Zsolt
    Khan, Khaurshid
    Akhtar, Naveed
    O'Rourke, Finton
    Shuaib, Ashfaq
    Demchuk, Andrew M.
    Alexandrov, Andrei V.
    STROKE, 2007, 38 (01) : 69 - 74